Abstract
Highlights What are the main findings? The importance of metabolite-mediated cell-cell communication (CCC) has been increasingly recognized recently, yet current metabolite-sensor databases remain inadequate and lack unified data collection standards, which greatly limits the scope of metabolite-mediated CCC that can be analyzed. Most current analytical tools follow traditional protein mediated CCC-inference frameworks and therefore struggle to accurately capture the complex interaction mechanisms between metabolites and their sensors. This highlights the need to develop more systematic and accurate inference strategies specifically tailored for metabolite-mediated CCC. What are the implications of the main findings? Higher-quality databases and more refined inference frameworks will enable researchers to more accurately understand the communication roles of metabolites in physiological and pathological conditions. With the systematic elucidation of metabolite signaling pathways becoming increasingly feasible, the mechanism and key targets underlying specific diseases would become clearer, providing critical insights for drug development and the design of therapeutic strategies.Highlights What are the main findings? The importance of metabolite-mediated cell-cell communication (CCC) has been increasingly recognized recently, yet current metabolite-sensor databases remain inadequate and lack unified data collection standards, which greatly limits the scope of metabolite-mediated CCC that can be analyzed. Most current analytical tools follow traditional protein mediated CCC-inference frameworks and therefore struggle to accurately capture the complex interaction mechanisms between metabolites and their sensors. This highlights the need to develop more systematic and accurate inference strategies specifically tailored for metabolite-mediated CCC. What are the implications of the main findings? Higher-quality databases and more refined inference frameworks will enable researchers to more accurately understand the communication roles of metabolites in physiological and pathological conditions. With the systematic elucidation of metabolite signaling pathways becoming increasingly feasible, the mechanism and key targets underlying specific diseases would become clearer, providing critical insights for drug development and the design of therapeutic strategies.Abstract Cell-cell communication (CCC) is essential for multicellular organisms, enabling different cell types to coordinate their activities in both physiological and pathological contexts, such as cell growth, proliferation, tumorigenesis, and immune responses. Metabolites represent an important class of signaling molecules, though their signaling roles were long underappreciated. Growing evidence has highlighted the critical involvement of metabolites in CCC, and the advent of single-cell RNA sequencing (scRNA-seq) has enabled high-resolution exploration of CCC events. This review summarizes existing metabolite-sensor databases and computational tools developed to identify metabolite-mediated CCC using scRNA-seq data. Nonetheless, these databases exhibit considerable variability due to lack of unified collection standards. Most computational tools were adapted from methods used for general CCC inference and often estimate metabolite abundance based on the expression of one or several related genes. Therefore, such approaches are not fully suited to capturing metabolite-mediated CCC due to the complexity of interaction mechanisms between metabolites and their sensors.
To address these challenges, improved computational methods and refined databases are needed for the reliable inference of metabolite-mediated CCC. This review discusses the current limitations in database construction and method development, and highlights potential directions for future improvement, including the incorporation of spatial omics and artificial intelligence (AI) approaches. Furthermore, the systematic inference and validation of metabolite-mediated CCC will pave the way for the discovery of novel drugs and therapeutic targets.